Howard Hughes Medical Institute acquired a new stake in shares of Lamb Weston Holdings Inc. (NYSE:LW) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,602 shares of the specialty retailer’s stock, valued at approximately $555,000.
A number of other large investors have also recently added to or reduced their stakes in the business. BlackRock Inc. increased its stake in Lamb Weston Holdings by 2.2% during the 2nd quarter. BlackRock Inc. now owns 11,872,986 shares of the specialty retailer’s stock valued at $522,887,000 after purchasing an additional 260,164 shares in the last quarter. FMR LLC increased its stake in Lamb Weston Holdings by 126.3% during the 1st quarter. FMR LLC now owns 3,331,242 shares of the specialty retailer’s stock valued at $140,112,000 after purchasing an additional 1,859,263 shares in the last quarter. Ruffer LLP bought a new stake in Lamb Weston Holdings during the 1st quarter valued at about $106,030,000. Kensico Capital Management Corp bought a new stake in Lamb Weston Holdings during the 1st quarter valued at about $82,900,000. Finally, Ameriprise Financial Inc. increased its stake in Lamb Weston Holdings by 30.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,878,916 shares of the specialty retailer’s stock valued at $82,750,000 after purchasing an additional 437,021 shares in the last quarter. Institutional investors and hedge funds own 79.78% of the company’s stock.
A number of analysts have weighed in on the stock. Zacks Investment Research lowered shares of Lamb Weston Holdings from a “buy” rating to a “hold” rating in a research note on Friday, July 28th. CL King assumed coverage on shares of Lamb Weston Holdings in a research note on Tuesday, May 23rd. They set a “strong-buy” rating and a $55.00 price objective for the company. Stifel Nicolaus lowered shares of Lamb Weston Holdings from a “buy” rating to a “hold” rating and raised their price objective for the company from $42.00 to $44.00 in a research note on Tuesday, July 4th. Bank of America Corporation raised their price objective on shares of Lamb Weston Holdings from $46.00 to $48.00 and gave the company a “buy” rating in a research note on Monday, July 10th. Finally, Morgan Stanley restated an “equal weight” rating and set a $46.00 price objective (up from $45.00) on shares of Lamb Weston Holdings in a research note on Wednesday, July 26th. Four equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Lamb Weston Holdings has a consensus rating of “Buy” and a consensus target price of $46.22.
ILLEGAL ACTIVITY WARNING: “Howard Hughes Medical Institute Acquires Shares of 12,602 Lamb Weston Holdings Inc. (LW)” was originally published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.truebluetribune.com/2017/09/17/howard-hughes-medical-institute-acquires-shares-of-12602-lamb-weston-holdings-inc-lw.html.
Shares of Lamb Weston Holdings Inc. (LW) traded up 0.69% during mid-day trading on Friday, hitting $46.39. 1,962,652 shares of the stock were exchanged. Lamb Weston Holdings Inc. has a 52-week low of $29.62 and a 52-week high of $49.94. The stock has a 50-day moving average price of $44.97 and a 200 day moving average price of $43.81. The firm has a market cap of $6.78 billion and a price-to-earnings ratio of 20.90.
Lamb Weston Holdings (NYSE:LW) last released its quarterly earnings results on Tuesday, July 25th. The specialty retailer reported $0.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.03. The firm had revenue of $833.00 million for the quarter, compared to analysts’ expectations of $810.85 million. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.29 earnings per share. On average, equities research analysts expect that Lamb Weston Holdings Inc. will post $2.30 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 1st. Stockholders of record on Friday, August 4th were issued a dividend of $0.1875 per share. The ex-dividend date was Wednesday, August 2nd. This represents a $0.75 annualized dividend and a dividend yield of 1.62%.
Lamb Weston Holdings Profile
Lamb Weston Holdings, Inc (Lamb Weston), is a supplier of frozen potato, sweet potato, appetizer and vegetable products to restaurants and retailers around the world. The Company’s segments include Global, Foodservice, Retail and Other. The Global segment includes operations associated with Lamb Weston’s business with large chain restaurant customers, whether those results are generated in the United States or abroad, as well as operations associated with retail and foodservice customers located outside of the United States and Canada.
Receive News & Ratings for Lamb Weston Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lamb Weston Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.